CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX), a specialty pharmaceutical company, is focused on the development, licensing and commercialization of pharmaceutical products through the leveraging of their validated drug delivery technology. The company has U.S. and international patents as well as other proprietary rights to technologies that encourage the absorption of drugs. For further information, visit the Company’s web site at www.cpexpharm.com.
- 17 years ago
QualityStocks
CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX)
Tags Rodman & Renshaw
Related Post
-
Scalability of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Tailings Model Represents Profitable Mining Approach Throughout The Americas
Sustainable mining company ESGold is stretching beyond its nascent Quebec mine tailings cleanup operation to…
-
QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present Corporate Update at Emerging Growth Conference on Aug. 20
Clene (NASDAQ: CLNN), a clinical-stage biopharmaceutical company developing treatments for neurodegenerative diseases such as ALS and…
-
QualityStocksNewsBreaks – FAVO Capital (OTC: FAVO) Acquires $190 Million Mixed-Use Property 1818 Park in All-Stock Deal
FAVO Capital (OTC: FAVO), a diversified finance company providing alternative revenue-based funding to SMBs, completed its…